FSM Wealth Advisors LLC Invests $260,000 in CME Group Inc. (NASDAQ:CME)

FSM Wealth Advisors LLC purchased a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 979 shares of the financial services provider's stock, valued at approximately $260,000.

Other institutional investors have also added to or reduced their stakes in the company. Golden State Wealth Management LLC lifted its position in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Alpine Bank Wealth Management purchased a new position in CME Group in the 1st quarter worth about $32,000. New Age Alpha Advisors LLC increased its stake in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after buying an additional 43 shares during the period. Knuff & Co LLC bought a new stake in CME Group during the 4th quarter valued at about $33,000. Finally, Banque Transatlantique SA bought a new stake in CME Group during the 4th quarter valued at about $35,000. Institutional investors own 87.75% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on CME shares. UBS Group upped their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Bank of America boosted their price target on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Raymond James Financial raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research note on Monday, March 10th. JPMorgan Chase & Co. decreased their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. Finally, Morgan Stanley upped their target price on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $258.20.

CME Group Trading Up 0.1%

CME opened at $275.82 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $99.39 billion, a price-to-earnings ratio of 27.75, a PEG ratio of 3.74 and a beta of 0.44. CME Group Inc. has a 12 month low of $193.17 and a 12 month high of $290.79. The stock has a fifty day moving average price of $276.00 and a 200-day moving average price of $257.35.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The firm had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the business posted $2.50 EPS. CME Group's revenue was up 10.4% on a year-over-year basis. As a group, equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's payout ratio is presently 50.30%.

Insider Buying and Selling at CME Group

In other news, Director Phyllis M. Lockett sold 1,060 shares of the firm's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the sale, the director owned 3,108 shares of the company's stock, valued at $863,651.04. This trade represents a 25.43% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Larry G. Gerdes sold 2,000 shares of the company's stock in a transaction dated Thursday, April 24th. The shares were sold at an average price of $264.10, for a total value of $528,200.00. Following the transaction, the director directly owned 38,651 shares in the company, valued at $10,207,729.10. This represents a 4.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,400 shares of company stock valued at $3,680,610. Corporate insiders own 0.30% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.